ImageneBio Inc
IMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,500 | $9,160 | $15,618 | $30,985 |
| % Growth | -61.8% | -41.3% | -49.6% | – |
| Cost of Goods Sold | $0 | $1,020 | $64,321 | $47,108 |
| Gross Profit | $3,500 | $8,140 | -$48,703 | -$16,123 |
| % Margin | 100% | 88.9% | -311.8% | -52% |
| R&D Expenses | $32,109 | $59,652 | $64,321 | $47,108 |
| G&A Expenses | $8,391 | $24,925 | $22,201 | $18,015 |
| SG&A Expenses | $8,391 | $24,925 | $22,201 | $18,015 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1,020 | -$64,321 | -$47,108 |
| Operating Expenses | $40,500 | $83,557 | $22,201 | $18,015 |
| Operating Income | -$37,000 | -$75,417 | -$70,904 | -$34,138 |
| % Margin | -1,057.1% | -823.3% | -454% | -110.2% |
| Other Income/Exp. Net | $445 | $7,089 | $2,139 | $23 |
| Pre-Tax Income | -$36,555 | -$68,328 | -$68,765 | -$34,115 |
| Tax Expense | $13 | -$162 | $0 | $0 |
| Net Income | -$36,568 | -$68,166 | -$68,765 | -$34,115 |
| % Margin | -1,044.8% | -744.2% | -440.3% | -110.1% |
| EPS | -1.02 | -1.63 | -1.9 | -0.95 |
| % Growth | 37.4% | 14.2% | -100% | – |
| EPS Diluted | -1.02 | -1.63 | -1.9 | -0.95 |
| Weighted Avg Shares Out | 48,258 | 41,735 | 36,188 | 35,975 |
| Weighted Avg Shares Out Dil | 48,258 | 41,735 | 36,188 | 35,975 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,373 | $7,111 | $2,149 | $23 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,526 | $1,020 | $751 | $544 |
| EBITDA | -$35,474 | -$74,397 | -$70,153 | -$33,594 |
| % Margin | -1,013.5% | -812.2% | -449.2% | -108.4% |